APA (7th ed.) Citation

Seremet, T., Jansen, Y., Planken, S., Njimi, H., Delaunoy, M., El Housni, H., . . . Neyns, B. (2019). Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy. Journal of Translational Medicine, 17(1), N.PAG. https://doi.org/10.1186/s12967-019-2051-8

Chicago Style (17th ed.) Citation

Seremet, Teofila, et al. "Undetectable Circulating Tumor DNA (ctDNA) Levels Correlate with Favorable Outcome in Metastatic Melanoma Patients Treated with Anti-PD1 Therapy." Journal of Translational Medicine 17, no. 1 (2019): N.PAG. https://doi.org/10.1186/s12967-019-2051-8.

MLA (9th ed.) Citation

Seremet, Teofila, et al. "Undetectable Circulating Tumor DNA (ctDNA) Levels Correlate with Favorable Outcome in Metastatic Melanoma Patients Treated with Anti-PD1 Therapy." Journal of Translational Medicine, vol. 17, no. 1, 2019, p. N.PAG, https://doi.org/10.1186/s12967-019-2051-8.